Catalyst Wire Dossier Catalyst Wire Dossier

DK-AH 269 CL

DK-AH 269 CL · Boehringer Ingelheim
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DK-AH 269 CL, covering 2014-10-15 to 2014-10-15. Get the full timeline:

Most recent: Clinical Trial Update: Metabolism and Pharmacokinetics of [14C]-DK-AH 269 CL in 12 Healthy Male Volunteers [Phase 1]

See pricing